All In MedTech

Device type · PGX

Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about PGX: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

PGX

Microbiology

Device class

Class II

FDA decisions since 2015

12

510(k), De Novo and PMA

Adverse event reports

0

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
Product code
PGX
Device class
Class II
Review panel
Microbiology
Regulation
21 CFR 866.2680

Latest FDA decisions

The 8 newest of 12 since 2015.

All decisions for PGX

9 more FDA decisions with a free account

Reports received

0

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

0

Injury reports

0

Death reports

0

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor

No reports to chart for this view.

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

No manufacturers to rank.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

No device problems coded.

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

No patient problems coded.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Cepheid

    Z-0215-2024 · Started Apr 24, 2023 · Posted by FDA Nov 2, 2023

    Reason given: pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.

    Cause as FDA categorized it: Unknown/Undetermined by firm

  • Cepheid

    Z-0216-2024 · Started Apr 24, 2023 · Posted by FDA Nov 2, 2023

    Reason given: pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.

    Cause as FDA categorized it: Unknown/Undetermined by firm

  • Luminex Corporation

    Z-2286-2019 · Started Feb 20, 2019 · Posted by FDA Aug 15, 2019

    Reason given: Through internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially sealed SCAs. The impact of a partial seal of the BSS could result in potential decrease of volume for each solution in the SCAs and...

    Cause as FDA categorized it: Process control

1 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.